Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
Cancer Letters|January 3, 2012
Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinomaHeiner Schäfer, Chantal Dieckmann, Olena Korniienko, et al.International Journal of Cancer|April 28, 2006
Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gammaMartin Kornacker, Gerhard Moldenhauer, Markus Herbst, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 8, 2009
In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry studyFlavio Forrer, Jianhua Chen, Melpomeni Fani, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Synergistic antitumor effect of bispecific CD19 x CD3 and CD19 x CD16 diabodies in a preclinical model of non-Hodgkin's lymphomaSergey M Kipriyanov, Björn Cochlovius, Holger J Schäfer, et al.Blood|June 27, 2013
Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cellsNathalie Fiegler, Sonja Textor, Annette Arnold, et al.International Journal of Cancer|June 25, 2011
Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascitesMarion G Ott, Frederik Marmé, Gerhard Moldenhauer, et al.Cancer Research|July 20, 2007
Target sequence accessibility limits activation-induced cytidine deaminase activity in primary mediastinal B-cell lymphomaSergey W Popov, Gerhard Moldenhauer, Beate Wotschke, et al.Proteomics|November 4, 2005
Systematic comparison of surface coatings for protein microarraysBirgit Guilleaume, Andreas Buness, Christian Schmidt, et al.International Journal of Cancer|September 19, 2014
Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMTKai Doberstein, Patrick N Harter, Uwe Haberkorn, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 14, 2010
Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostateGeorgios Kallifatidis, Sabrina Labsch, Vanessa Rausch, et al.Pageof 7